APO Research

APO RESEARCH · REPORT

Venous Thromboembolism (VTE) Prevention Software

Selected research

Market Structure

Global Venous Thromboembolism (VTE) Prevention Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Venous Thromboembolism (VTE) Prevention Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Venous Thromboembolism (VTE) Prevention Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Venous Thromboembolism (VTE) Prevention Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Venous Thromboembolism (VTE) Prevention Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Venous Thromboembolism (VTE) Prevention Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Venous Thromboembolism (VTE) Prevention Software include Aidoc, Xiangyu Medical, Xunfei Healthcare, Shanghai SYNYI AI, Shanghai Clinbrain, SmartCode Technology, Zhixuan Internet, Biovision Software and Lianyungang Xunda Seal Engraving Service, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Venous Thromboembolism (VTE) Prevention Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Venous Thromboembolism (VTE) Prevention Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Venous Thromboembolism (VTE) Prevention Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Venous Thromboembolism (VTE) Prevention Software market size, projected growth trends, production technologies, key applications, and end-use industries.

Venous Thromboembolism (VTE) Prevention Software Segment by Company

Aidoc

Xiangyu Medical

Xunfei Healthcare

Shanghai SYNYI AI

Shanghai Clinbrain

SmartCode Technology

Zhixuan Internet

Biovision Software

Lianyungang Xunda Seal Engraving Service

Donghua Medical Technology

Guangzhou Laino Information Technology

Venous Thromboembolism (VTE) Prevention Software Segment by Type

Cloud-based

On-premise

Venous Thromboembolism (VTE) Prevention Software Segment by Application

Hospital

Clinic

Other

Venous Thromboembolism (VTE) Prevention Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Thromboembolism (VTE) Prevention Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venous Thromboembolism (VTE) Prevention Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Thromboembolism (VTE) Prevention Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Venous Thromboembolism (VTE) Prevention Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Venous Thromboembolism (VTE) Prevention Software industry.

Chapter 3: Detailed analysis of Venous Thromboembolism (VTE) Prevention Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Venous Thromboembolism (VTE) Prevention Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cloud-based Table 3. Key Players of On-premise Table 4. Global Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Region (2021-2026) Table 11. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Region (2027-2032) Table 13. Venous Thromboembolism (VTE) Prevention Software Industry Trends Table 14. Venous Thromboembolism (VTE) Prevention Software Industry Drivers Table 15. Venous Thromboembolism (VTE) Prevention Software Industry Opportunities and Challenges Table 16. Venous Thromboembolism (VTE) Prevention Software Industry Restraints Table 17. Global Venous Thromboembolism (VTE) Prevention Software Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Company (2021-2026) Table 19. Global Venous Thromboembolism (VTE) Prevention Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Venous Thromboembolism (VTE) Prevention Software Key Company Head Office and Area Served Table 21. Global Venous Thromboembolism (VTE) Prevention Software Company, Product Type & Application Table 22. Global Venous Thromboembolism (VTE) Prevention Software Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Venous Thromboembolism (VTE) Prevention Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Type (2021-2026) Table 29. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Type (2027-2032) Table 30. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Application (2021-2026) Table 34. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Application (2027-2032) Table 35. Aidoc Company Information Table 36. Aidoc Business Overview Table 37. Aidoc Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Aidoc Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 39. Aidoc Recent Development Table 40. Xiangyu Medical Company Information Table 41. Xiangyu Medical Business Overview Table 42. Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 44. Xiangyu Medical Recent Development Table 45. Xunfei Healthcare Company Information Table 46. Xunfei Healthcare Business Overview Table 47. Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 49. Xunfei Healthcare Recent Development Table 50. Shanghai SYNYI AI Company Information Table 51. Shanghai SYNYI AI Business Overview Table 52. Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 54. Shanghai SYNYI AI Recent Development Table 55. Shanghai Clinbrain Company Information Table 56. Shanghai Clinbrain Business Overview Table 57. Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 59. Shanghai Clinbrain Recent Development Table 60. SmartCode Technology Company Information Table 61. SmartCode Technology Business Overview Table 62. SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 64. SmartCode Technology Recent Development Table 65. Zhixuan Internet Company Information Table 66. Zhixuan Internet Business Overview Table 67. Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 69. Zhixuan Internet Recent Development Table 70. Biovision Software Company Information Table 71. Biovision Software Business Overview Table 72. Biovision Software Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Biovision Software Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 74. Biovision Software Recent Development Table 75. Lianyungang Xunda Seal Engraving Service Company Information Table 76. Lianyungang Xunda Seal Engraving Service Business Overview Table 77. Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 79. Lianyungang Xunda Seal Engraving Service Recent Development Table 80. Donghua Medical Technology Company Information Table 81. Donghua Medical Technology Business Overview Table 82. Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 84. Donghua Medical Technology Recent Development Table 85. Guangzhou Laino Information Technology Company Information Table 86. Guangzhou Laino Information Technology Business Overview Table 87. Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 89. Guangzhou Laino Information Technology Recent Development Table 90. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) Table 96. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032) Table 97. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) Table 103. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032) Table 104. China Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026) & (US$ Million) Table 105. China Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032) & (US$ Million) Table 106. China Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026) & (US$ Million) Table 107. China Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) Table 114. Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Venous Thromboembolism (VTE) Prevention Software Product Image Figure 2. Global Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Type: 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Venous Thromboembolism (VTE) Prevention Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 13. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Venous Thromboembolism (VTE) Prevention Software Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Type (2021-2032) Figure 20. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Application (2021-2032) Figure 22. North America Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 23. North America Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032) Figure 24. North America Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032) Figure 25. North America Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 26. United States Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 27. Canada Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 29. Europe Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 30. Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032) Figure 31. Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032) Figure 32. Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 33. Germany Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 34. France Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 36. Italy Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 37. Russia Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 39. China Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 40. China Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032) Figure 41. China Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032) Figure 42. Asia Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 43. Asia Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032) Figure 44. Asia Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032) Figure 45. Asia Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 46. Japan Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 50. India Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 51. Australia Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 56. Brazil Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 61. UAE Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 63. Chile Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aidoc
  • Xiangyu Medical
  • Xunfei Healthcare
  • Shanghai SYNYI AI
  • Shanghai Clinbrain
  • SmartCode Technology
  • Zhixuan Internet
  • Biovision Software
  • Lianyungang Xunda Seal Engraving Service
  • Donghua Medical Technology
  • Guangzhou Laino Information Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Venous Thromboembolism (VTE) Prevention Software Growth Trends by Region
  13. 1.5.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2021-2026)
  15. 1.5.3 Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Venous Thromboembolism (VTE) Prevention Software Market Dynamics
  1. 2.1 Venous Thromboembolism (VTE) Prevention Software Industry Trends
  2. 2.2 Venous Thromboembolism (VTE) Prevention Software Industry Drivers
  3. 2.3 Venous Thromboembolism (VTE) Prevention Software Industry Opportunities and Challenges
  4. 2.4 Venous Thromboembolism (VTE) Prevention Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Venous Thromboembolism (VTE) Prevention Software Revenue by Company (2021-2026)
  2. 3.2 Global Venous Thromboembolism (VTE) Prevention Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Venous Thromboembolism (VTE) Prevention Software Key Company Head office and Area Served
  4. 3.4 Global Venous Thromboembolism (VTE) Prevention Software Company, Product Type & Application
  5. 3.5 Global Venous Thromboembolism (VTE) Prevention Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Venous Thromboembolism (VTE) Prevention Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Venous Thromboembolism (VTE) Prevention Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Venous Thromboembolism (VTE) Prevention Software Tier 1, Tier 2, and Tier 3
4 Venous Thromboembolism (VTE) Prevention Software Market by Type
  1. 4.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2032)
  3. 4.3 Global Venous Thromboembolism (VTE) Prevention Software Market Size Share by Type (2021-2032)
5 Venous Thromboembolism (VTE) Prevention Software Market by Application
  1. 5.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2032)
  3. 5.3 Global Venous Thromboembolism (VTE) Prevention Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Aidoc
  2. 6.1.1 Aidoc Company Information
  3. 6.1.2 Aidoc Business Overview
  4. 6.1.3 Aidoc Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Aidoc Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  6. 6.1.5 Aidoc Recent Developments
  7. 6.2 Xiangyu Medical
  8. 6.2.1 Xiangyu Medical Company Information
  9. 6.2.2 Xiangyu Medical Business Overview
  10. 6.2.3 Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  12. 6.2.5 Xiangyu Medical Recent Developments
  13. 6.3 Xunfei Healthcare
  14. 6.3.1 Xunfei Healthcare Company Information
  15. 6.3.2 Xunfei Healthcare Business Overview
  16. 6.3.3 Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  18. 6.3.5 Xunfei Healthcare Recent Developments
  19. 6.4 Shanghai SYNYI AI
  20. 6.4.1 Shanghai SYNYI AI Company Information
  21. 6.4.2 Shanghai SYNYI AI Business Overview
  22. 6.4.3 Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  24. 6.4.5 Shanghai SYNYI AI Recent Developments
  25. 6.5 Shanghai Clinbrain
  26. 6.5.1 Shanghai Clinbrain Company Information
  27. 6.5.2 Shanghai Clinbrain Business Overview
  28. 6.5.3 Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  30. 6.5.5 Shanghai Clinbrain Recent Developments
  31. 6.6 SmartCode Technology
  32. 6.6.1 SmartCode Technology Company Information
  33. 6.6.2 SmartCode Technology Business Overview
  34. 6.6.3 SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  36. 6.6.5 SmartCode Technology Recent Developments
  37. 6.7 Zhixuan Internet
  38. 6.7.1 Zhixuan Internet Company Information
  39. 6.7.2 Zhixuan Internet Business Overview
  40. 6.7.3 Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  42. 6.7.5 Zhixuan Internet Recent Developments
  43. 6.8 Biovision Software
  44. 6.8.1 Biovision Software Company Information
  45. 6.8.2 Biovision Software Business Overview
  46. 6.8.3 Biovision Software Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biovision Software Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  48. 6.8.5 Biovision Software Recent Developments
  49. 6.9 Lianyungang Xunda Seal Engraving Service
  50. 6.9.1 Lianyungang Xunda Seal Engraving Service Company Information
  51. 6.9.2 Lianyungang Xunda Seal Engraving Service Business Overview
  52. 6.9.3 Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  54. 6.9.5 Lianyungang Xunda Seal Engraving Service Recent Developments
  55. 6.10 Donghua Medical Technology
  56. 6.10.1 Donghua Medical Technology Company Information
  57. 6.10.2 Donghua Medical Technology Business Overview
  58. 6.10.3 Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  60. 6.10.5 Donghua Medical Technology Recent Developments
  61. 6.11 Guangzhou Laino Information Technology
  62. 6.11.1 Guangzhou Laino Information Technology Company Information
  63. 6.11.2 Guangzhou Laino Information Technology Business Overview
  64. 6.11.3 Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  66. 6.11.5 Guangzhou Laino Information Technology Recent Developments
7 North America
  1. 7.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
  2. 7.2 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Type
  3. 7.2.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026)
  4. 7.2.2 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032)
  5. 7.2.3 North America Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032)
  6. 7.3 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Application
  7. 7.3.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026)
  8. 7.3.2 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032)
  9. 7.3.3 North America Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032)
  10. 7.4 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country
  11. 7.4.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  13. 7.4.3 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
  14. 7.4.4 North America Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
  2. 8.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Type
  3. 8.2.1 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032)
  6. 8.3 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Application
  7. 8.3.1 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032)
  10. 8.4 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country
  11. 8.4.1 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
  2. 9.2 China Venous Thromboembolism (VTE) Prevention Software Market Size by Type
  3. 9.2.1 China Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026)
  4. 9.2.2 China Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032)
  5. 9.2.3 China Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032)
  6. 9.3 China Venous Thromboembolism (VTE) Prevention Software Market Size by Application
  7. 9.3.1 China Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026)
  8. 9.3.2 China Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032)
  9. 9.3.3 China Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
  2. 10.2 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Type
  3. 10.2.1 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032)
  6. 10.3 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Application
  7. 10.3.1 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032)
  10. 10.4 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Country
  11. 10.4.1 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research